PD
PDEX.US Pro-Dex Inc
- Market cap
- USD 210M
- P/E
- 18.1x
- P/B
- 4.25x
- ROE
- 24.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.
Is PDEX.US undervalued?
Graham numberPDEX.US trades 84.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pro-Dex Inc fundamental analysis
No fundamental analysis for Pro-Dex Inc yet.
Pro-Dex Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pro-Dex Inc
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various indu…
Full company profilePro-Dex Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pro-Dex Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 21.9M | 22.5M | 27.2M | 34.8M | 42.0M | 42.0M | 46.1M | 53.8M | 66.6M | 77.5M | 82.2M |
| Gross Profit | 7.19M | 7.94M | 9.78M | 13.1M | 13.1M | 13.1M | 12.7M | 14.6M | 19.5M | 24.3M | 27.4M |
| Operating Income | 2.73M | 2.39M | 5.00M | 7.07M | 5.12M | 5.12M | 5.76M | 7.17M | 10.7M | 13.0M | 14.1M |
| EBITDA | 3.40M | 3.96M | 5.43M | 8.71M | 6.88M | 6.88M | 10.8M | 4.35M | 14.1M | 14.4M | 15.7M |
| Net Income | 5.08M | 1.62M | 4.15M | 6.11M | 4.57M | 4.57M | 7.07M | 2.13M | 8.98M | 13.7M | 12.2M |
| EPS | 1.25 | 0.37 | 0.97 | 1.50 | 1.16 | 1.21 | 1.95 | 0.60 | 2.67 | 4.12 | 3.68 |
| Balance Sheet | |||||||||||
| Total Assets | 16.4M | 19.9M | 25.5M | 31.1M | 49.1M | 49.1M | 51.8M | 52.5M | 61.2M | 74.5M | 76.6M |
| Total Liabilities | 2.64M | 2.64M | 8.51M | 12.1M | 23.7M | 23.7M | 20.2M | 21.6M | 24.6M | 26.9M | 27.2M |
| Shareholders' Equity | 13.7M | 17.3M | 17.0M | 19.1M | 25.4M | 25.4M | 31.6M | 30.9M | 36.6M | 47.6M | 49.3M |
| Cash & Short-term Investments | 4.92M | 7.41M | 10.4M | 8.98M | 1.60M | 1.60M | 4.07M | 6.85M | 7.16M | 9.34M | 13.0M |
| Total Debt | 119K | 41.0K | 4.56M | 7.02M | 16.0M | 16.0M | 14.8M | 13.5M | 16.6M | 18.1M | 19.0M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.24M | 3.10M | 3.33M | 5.90M | -2.08M | -847K | 5.46M | 6.20M | -1.68M | 7.24M | 26.0M |
| Capital Expenditure | 638K | 934K | 1.40M | 565K | 8.31M | 1.67M | 974K | 983K | 1.25M | 483K | 1.38M |
| Free Cash Flow | 2.60M | 2.16M | 1.93M | 5.33M | -10.4M | -2.52M | 4.49M | 5.22M | -2.93M | 6.76M | 24.6M |
| Ratios | |||||||||||
| ROE | 37.1% | 9.4% | 24.4% | 32.1% | 18.0% | 18.0% | 22.4% | 6.9% | 24.5% | 28.7% | 24.7% |
| ROA | 31.1% | 8.1% | 16.3% | 19.6% | 9.3% | 9.3% | 13.7% | 4.1% | 14.7% | 18.3% | 15.9% |
| Net Profit Margin | 23.2% | 7.2% | 15.3% | 17.5% | 10.9% | 10.9% | 15.3% | 4.0% | 13.5% | 17.6% | 14.8% |
| Debt to Equity | 0.01x | 0.00x | 0.27x | 0.37x | 0.63x | 0.63x | 0.47x | 0.44x | 0.45x | 0.38x | 0.38x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Pro-Dex Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 89.0K | 0.02 | 1.3% |
| 2022 | - | - | - |
| 2021 | USD 259K | 0.07 | 5.7% |
| 2020 | USD 15.0K | 0.00 | 0.2% |
| 2019 | USD 23.0K | 0.01 | 0.6% |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:3 on Jun 18, 2010.
Who owns Pro-Dex Inc
- Insiders 36.45%
- Institutions 37.86%
- Public & others 25.69%
- Shares outstanding 3.20M
- Free float 1.49M
Top funds holding PDEX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 56.3K | 1.76% | 0.00% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 55.9K | 1.75% | 0.00% | Sep 2026 |
| Fidelity Small Cap Index | 22.7K | 0.71% | 0.00% | Aug 2026 |
| DFA U.S. Small Cap I | 21.9K | 0.69% | 0.00% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 18.8K | 0.59% | -0.38% | Oct 2026 |
| Vanguard Russell 2000 ETF | 12.0K | 0.38% | +1.02% | Sep 2026 |
| Dimensional US Small Cap ETF | 8.82K | 0.28% | 0.00% | Oct 2026 |
| Fidelity Extended Market Index | 8.18K | 0.26% | -10.45% | Sep 2026 |
| First Trust Dow Jones Sel MicroCap ETF | 7.52K | 0.23% | 0.00% | Oct 2026 |
| GS US Sm Cp CORE Eq Base Inc USD Snap | 7.40K | 0.23% | +1.09% | Aug 2026 |
| Bridge Builder Small Cap Fund | 6.65K | 0.21% | 0.00% | Oct 2026 |
| iShares Micro-Cap ETF | 6.36K | 0.20% | 0.00% | Oct 2026 |
| DFA U.S. Core Equity 1 I | 5.19K | 0.16% | +2.86% | Sep 2026 |
| DFA U.S. Core Equity 2 Instl | 4.95K | 0.15% | +1.83% | Sep 2026 |
| Russell Inv US Small Cap Equity Y | 4.95K | 0.15% | +58.58% | Sep 2026 |
| Schwab Small Cap Index | 4.65K | 0.15% | -9.95% | Sep 2026 |
| Fidelity Total Market Index | 4.06K | 0.13% | -0.05% | Sep 2026 |
| DFA US Micro Cap I | 3.94K | 0.12% | 0.00% | Sep 2026 |
| Stt Strt SPDR® Russell2000 US SmCapETF | 3.92K | 0.12% | -6.17% | Oct 2026 |
| iShares Russell 2000 Small-Cap Idx Instl | 3.67K | 0.11% | 0.00% | Sep 2026 |
Top institutions holding PDEX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 153K | 4.79% | +0.43% | Jun 2026 |
| Vanguard Capital Management, LLC | 82.3K | 2.57% | -26.09% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 62.6K | 1.96% | +9.77% | Sep 2026 |
| Punch & Associates Inv Mgmt Inc | 52.7K | 1.65% | -14.58% | Jun 2026 |
| Geode Capital Management, LLC | 49.6K | 1.55% | +2.67% | Jun 2026 |
| JPMorgan Chase & Co | 32.3K | 1.01% | +0.78% | Jun 2026 |
| State Street Corp | 31.3K | 0.98% | -5.45% | Jun 2026 |
| The Goldman Sachs Group Inc | 18.7K | 0.58% | +84.51% | Jun 2026 |
| Ellsworth Advisors, LLC | 16.9K | 0.53% | 0.00% | Sep 2026 |
| Appleseed Capital | 16.5K | 0.52% | 0.00% | Jun 2026 |
| BNP Paribas Arbitrage, SA | 15.9K | 0.50% | +20.49% | Jun 2026 |
| Northern Trust Corp | 15.6K | 0.49% | -66.56% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 14.3K | 0.45% | +15.24% | Jun 2026 |
| LPL Financial Corp | 14.3K | 0.45% | +9.47% | Jun 2026 |
| Jane Street Group LLC | 13.6K | 0.43% | 0.00% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 13.3K | 0.42% | +1.78% | Jun 2026 |
| Bank of New York Mellon Corp | 11.6K | 0.36% | +4.77% | Jun 2026 |
| Corsair Capital Management LLC | 10.8K | 0.34% | 0.00% | Jun 2026 |
| Bard Associates Inc | 9.80K | 0.31% | -7.26% | Jun 2026 |
| HRT FINANCIAL LLC | 9.51K | 0.30% | 0.00% | Jun 2026 |
Pro-Dex Inc company profile
- Company name
- Pro-Dex Inc
- Ticker
- PDEX.US
- Exchange
- USA Stocks
- Listed since
- Aug 18, 1995
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 201
- Fiscal year end
- June
- Address
- 2361 McGaw Avenue, Irvine, CA, United States, 92614
- Phone
- 949 769 3200
- Website
- pro-dex.com
About Pro-Dex Inc
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Pro-Dex Inc management
2- Mr. Richard Lee Van Kirk Jr.CEO, COO & Director · born 1961
- Ms. Alisha K. CharltonCFO & Corporate Secretary · born 1970